Bloomberg Businessweek

Bloomberg Markets with Carol Massar and Cory Johnson.\u0010\u0010GUEST:\u0010David Wilson\u0010Stocks Editor\u0010Bloomberg News\u0010Discussing his "Stock of the Day" Pulse Biosciences (PLSE). Pulse Biosciences Inc.'s shares plunged as much as 40 percent after the medical-device developer withdrew an application for U.S. approval of its first product. The company said it couldn't provide additional data requested by regulators within a 90-day review period, which ended yesterday. Pulse said it plans to reapply once the data has been generated.